leads a College of Medicine – Phoenix based research team[1]
recently received a substantial NIH grant to discover novel antidepressants
depression, epigenetics and transcriptomics · discover novel antidepressants
Reviewed sources document depression, epigenetics and transcriptomics and discover novel antidepressants. Explore attributed publications and research affiliations.
Explore researchleads a College of Medicine – Phoenix based research team[1]
depression, epigenetics and transcriptomics[1]
discover novel antidepressants[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
7 source claims · Reviewed Sep 9, 2026
Biographical context: recently received a substantial NIH grant to discover novel antidepressants
Deveroux Ferguson, PhD, leads a College of Medicine – Phoenix based research team studying depression, epigenetics and transcriptomics. Dr. Ferguson recently received a substantial NIH grant to discover novel antidepressants.
Degree: PhD
Deveroux Ferguson, PhD, leads a College of Medicine – Phoenix based research team studying depression, epigenetics and transcriptomics. Dr. Ferguson recently received a substantial NIH grant to discover novel antidepressants.
Identity: Deveroux Ferguson, PhD
Deveroux Ferguson, PhD, leads a College of Medicine – Phoenix based research team studying depression, epigenetics and transcriptomics. Dr. Ferguson recently received a substantial NIH grant to discover novel antidepressants.
Professional role: leads a College of Medicine – Phoenix based research team
Deveroux Ferguson, PhD, leads a College of Medicine – Phoenix based research team studying depression, epigenetics and transcriptomics. Dr. Ferguson recently received a substantial NIH grant to discover novel antidepressants.
Official profile: Official profile
Deveroux Ferguson, PhD, leads a College of Medicine – Phoenix based research team studying depression, epigenetics and transcriptomics. Dr. Ferguson recently received a substantial NIH grant to discover novel antidepressants.
Research interests: depression, epigenetics and transcriptomics
research team studying depression, epigenetics and transcriptomics
Research interests: discover novel antidepressants
Deveroux Ferguson, PhD, leads a College of Medicine – Phoenix based research team studying depression, epigenetics and transcriptomics. Dr. Ferguson recently received a substantial NIH grant to discover novel antidepressants.